Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000390482

Medchemexpress LLC Darolutamide-d4 | 2484757-20-0 | 98.6% | 402.87 | 500 UG
SDP

Catalog No. 5000390482
Encompass_Preferred

Darolutamide-d4 is a deuterium-labeled version of Darolutamide. It is an orally active, competitive androgen receptor (AR) antagonist that inhibits testosterone-induced AR nuclear translocation and transcriptional activation. This compound selectively affects AR-positive cells by inhibiting AR-dependent signaling pathways, and its active metabolite maintains full antagonistic activity against AR mutants. It can be used for research on prostate cancer, including androgen receptor-dependent prostate cancer.

  • Can be used as a tracer.
  • Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

Catalog No. 50-003-90482 Supplier Medchemexpress LLC Supplier No. HY16985S500UG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Darolutamide-d4 is a deuterium-labeled version of Darolutamide. It is an orally active, competitive androgen receptor (AR) antagonist that inhibits testosterone-induced AR nuclear translocation and transcriptional activation. This compound selectively affects AR-positive cells by inhibiting AR-dependent signaling pathways, and its active metabolite maintains full antagonistic activity against AR mutants. It can be used for research on prostate cancer, including androgen receptor-dependent prostate cancer.

  • Can be used as a tracer.
  • Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.